DOI: 10.1038/NBT1092-1112
关键词:
摘要: Significant advances in the areas of identification disease susceptibility genes and gene transfer technologies have fueled new initiatives cellular engineering as a means for treating metabolic disease. This article utilizes findings from such work blueprint discussion prospects therapy diabetes mellitus.